tiprankstipranks
Trending News
More News >
aTyr Pharma (ATYR)
NASDAQ:ATYR
US Market

aTyr Pharma (ATYR) Technical Analysis

Compare
2,088 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
aTyr Pharma’s (ATYR) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting aTyr Pharma is a Sell.
aTyr Pharma’s (ATYR) 20-Day exponential moving average is 3.19, while aTyr Pharma’s (ATYR) share price is $3.35, making it a Buy.
aTyr Pharma’s (ATYR) 50-Day exponential moving average is 3.31, while aTyr Pharma’s (ATYR) share price is $3.35, making it a Buy.

aTyr Pharma (ATYR) Pivot Points

Apr 26, 2025, 04:12 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.30
3.37
3.45
3.52
3.60
3.67
3.75
Fibonacci
3.37
3.43
3.47
3.52
3.58
3.62
3.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

aTyr Pharma (ATYR) Moving Averages

Apr 26, 2025, 04:12 PM
Period
Simple
Exponential
MA5
3.36Buy
3.36Buy
MA10
3.16Buy
3.24Buy
MA20
3.03Buy
3.19Buy
MA50
3.41Buy
3.31Buy
MA100
3.47Sell
3.27Buy
MA200
2.86Buy
2.81Buy
aTyr Pharma’s (ATYR) 10-Day exponential moving average is 3.24, while aTyr Pharma’s (ATYR) share price is $3.35, making it a Buy.
aTyr Pharma’s (ATYR) 100-Day exponential moving average is 3.27, while aTyr Pharma’s (ATYR) share price is $3.35, making it a Buy.
aTyr Pharma’s (ATYR) stock price is $3.35 and aTyr Pharma’s (ATYR) 50-day simple moving average is 3.41, creating a Buy signal.
aTyr Pharma’s (ATYR) stock price is $3.35 and aTyr Pharma’s (ATYR) 100-day simple moving average is 3.47, creating a Sell signal.
aTyr Pharma’s (ATYR) stock price is $3.35 and aTyr Pharma’s (ATYR) 200-day simple moving average is 2.86, creating a Buy signal.

aTyr Pharma (ATYR) Technical Indicators

Apr 26, 2025, 04:12 PM
Name
Value
Implied Action
RSI (14)
57.05
Neutral
STOCH (9,6)
82.90
Sell
STOCHRSI (14)
87.47
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
14.08
Buy
Williams %R
-14.75
Sell
CCI (14)
140.43
Sell
ATR (14)
0.28
-
Ultimate Oscillator
57.85
Neutral
ROC
23.66
Buy
aTyr Pharma’s (ATYR) Relative Strength Index (RSI) is 57.05, creating a Neutral signal.
aTyr Pharma’s (ATYR) Trend Strength Indicator (ADX) is 14.08, creating a Buy signal.
aTyr Pharma’s (ATYR) Commodity Channel Index (CCI) is 140.43, creating a Sell signal.
aTyr Pharma’s (ATYR) Price Rate of Change (ROC) is 23.66, creating a Buy signal.

FAQ

Is ATYR a Buy, Hold, or Sell?
Based on ATYR’s technical indicators, ATYR is a Buy.
    What is ATYR’s RSI (14)?
    ATYR’s RSI (14) is 57.05, which suggests ATYR is a Neutral.
      What is ATYR’s MACD?
      ATYR’s MACD is >-0.01, which suggests ATYR is a Sell.
        What is ATYR’s 5-day moving average?
        ATYR’s 5-day moving average is 3.36, which suggests ATYR is a Buy.
          What is ATYR’s 20-day moving average?
          ATYR 20-day moving average is 3.03, which suggests ATYR is a Buy.
            What is ATYR’s 50-day moving average?
            ATYR’s 50-day moving average is 3.41, which suggests ATYR is a Buy.
              What is ATYR’s 200-day moving average?
              ATYR’s 200-day moving average is 2.86, which suggests ATYR is a Buy.
                What is ATYR’s Williams % R (14)?
                ATYR’s Williams % R (14) is -14.75, which suggests ATYR is a Sell.
                  What is ATYR’s CCI (14)?
                  ATYR’s CCI (14) is 140.43, which suggests ATYR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis